CNS-LEUKEMIA IN ACUTE LEUKEMIA PATIENTS: DIAGNOSIS, PROPHILACTIC, TREATMENT, PROGNOSIS
Themodernproblem’scondition in diagnosis, prophylaxis and treatment of central nervous system lesion (CNS-leukemia) in acute leukemia patients are observed in the article. Investigation results of 47 acute lymphoblastic leukemia patients’ blood serum and liquor thymidine kinase content are presented in the article. It was proved, that blood serum and liquor thymidine kinase content is reliable prognostic factor of course of decease. It can predict chemotherapy resistant formation and complications arising, in particularly, CNS-leukemia.